Otsuka and Lundbeck report data from three PTSD treatment trials

Otsuka Pharmaceutical Development & Commercialization and Lundbeck Pharmaceuticals have reported results from three clinical trials evaluating the combination of brexpiprazole and sertraline in treating adults with post-traumatic stress disorder (PTSD).